Latest News - Partnerships

Friday, April 21, 2017 | Partnerships, Retina, ThromboGenics

Bicycle Therapeutics Announces a Candidate Preclinical Milestone in Its Ophthalmology Alliance with ThromboGenics

Bicycle Therapeutics announced the receipt of a preclinical milestone in connection with the advancement of a Bicycle into preclinical development for the treatment of diabetic macular edema, under it…

Read the full story

Wednesday, April 19, 2017 | Cataract Surgery, Partnerships, Carl Zeiss Meditec

First SMILE Laser Eye Surgery Procedures for US Navy Performed at Naval Medical Center San Diego

The first Zeiss ReLEx SMILE procedures for US Navy personnel were performed by Cmdr. John B. Cason, MD, Program Director, Navy Refractive Surgery Center San Diego. These procedures for the US Navy fol…

Read the full story

Wednesday, April 19, 2017 | Partnerships

H.I.G. Capital Makes a Strategic Investment in Barnet Dulaney Perkins and Southwestern Eye Center

H.I.G. Capital, a global private equity investment firm with $21 billion of equity capital under management, announced that one of its affiliates has made a strategic investment in Barnet Dulaney Perk…

Read the full story

Tuesday, April 18, 2017 | Partnerships, DigiSight Technologies

DigiSight Technologies Deploys Paxos Solution In Banner Health Emergency Departments

DigiSight Technologies announced that it has launched Paxos, a telehealth solution that enables health care teams to collaborate and make informed decisions at the point-of-care, at 13 Banner Health f…

Read the full story

Tuesday, April 18, 2017 | Partnerships, Imprimis Pharmaceuticals

Imprimis Pharmaceuticals and Precision Lens Sign Agreement to Expand Imprimis’ Ophthalmic Portfolio Market

Imprimis Pharmaceuticals and Cameron Ehlen Group, d/b/a Precision Lens, announced the signing of a 3-year exclusive sales representation agreement. Under the agreement, Precision Lens will deploy a de…

Read the full story

Wednesday, April 12, 2017 | Partnerships, Novartis

Commentary: Novartis Finds Its Next Mass-Market Ophthalmology Drug Candidate at a Small Virtual Biotech With a Global View

Like me, you may never have heard about Lubris BioPharma before today. But Novartis has. And that is by far more important. Today the pharma giant reached out and exercised an option on a recombinant …

Read the full story

Tuesday, April 04, 2017 | Partnerships, Paragon BioTeck 

Paragon Vision Sciences Announces Educational Partnerships with Leading Institutions and Organizations

Paragon Vision Sciences announced that it has entered into a series of educational partnership programs with several leading research institutions and organizations devoted to advancing eye care pract…

Read the full story

Friday, March 31, 2017 | Partnerships, Practice Development

Riata Capital Group Announces Formation of Acuity Eyecare

Riata Capital Group announced the formation of Acuity Eyecare Holdings, a company that will own and operate North American eyecare groups and optometry practices. Acuity launches with a strong platfor…

Read the full story

Friday, March 31, 2017 | Partnerships, Clearside Biomedical

Clearside Biomedical Enters into Strategic Collaboration with EyeKor to Support Clinical Development Efforts

Clearside Biomedical announced that it has entered into a strategic collaboration with EyeKor to support Clearside’s ophthalmic clinical trial activities. Clearside is currently conducting ph…

Read the full story

Thursday, March 30, 2017 | Partnerships, CooperVision

CooperVision Becomes First Major Contact Lens Manufacturer to Join The Vision Council

As part of its broad commitment to engaging and educating eye care professionals on clinical and marketplace advances, CooperVision announced today that it is the first major contact lens manufacturer…

Read the full story

Tuesday, March 28, 2017 | Partnerships

International Keratoconus Society Partners with Scleral Lens Society

The International Keratoconus Academy of Eye Care Professionals (IKA), a collaborative optometric and ophthalmologic organization established to promote ongoing professional education and scientific d…

Read the full story

Wednesday, March 22, 2017 | Glaucoma, Partnerships, Ora

AXIM Biotech Retains ORA to Manage Glaucoma & Dry Eye Indications Product Development and Clinical Trials

Axim Biotechnologies is retaining the services from contract research organization Ora to run the company’s upcoming product development and clinical trials for the treatment of glaucoma and dry…

Read the full story

Tuesday, March 21, 2017 | Clinical Trials, Partnerships

Nemus Bioscience Signs Agreement with Nanomerics to Advance NB1111 for the Treatment of Glaucoma Using Molecular Envelope Technology

Nemus Bioscience announced that the company has signed a development agreement with Nanomerics of the United Kingdom to develop a topical ocular formulation of tetrahydrocannabinol-valine-hemisuccinat…

Read the full story

Thursday, March 16, 2017 | Blindness, Partnerships, Allergan, Prevent Blindness

Prevent Blindness and Allergan Work Together Through 'See America' to Promote Healthy Vision

Prevent Blindness, the nation’s oldest volunteer eye health and safety group, and Allergan, a global leader in eye care for nearly 70 years, have embarked on a joint effort to promote healthy vi…

Read the full story

Monday, March 13, 2017 | Partnerships

Macula Vision Research Foundation and VisionCare Announce New Partnership

The Macula Vision Research Foundation, an organization dedicated to finding a cure for macular degeneration and other diseases, along with VisionCare, which focuses on the development, manufacturing a…

Read the full story
Load More